POPULARITY
5 episodes with international aids society
2 episodes with international aids society
4 episodes with international aids society
3 episodes with international aids society
2 episodes with international aids society
3 episodes with international aids society
2 episodes with international aids society
About this episode: In 2003, George W. Bush's President's Emergency Plan for AIDS Relief (PEPFAR) was the largest commitment to a single disease in U.S. history. Renewed under every subsequent presidency since, PEPFAR has saved more than 25 million lives and prevented some 5 million perinatal infections globally. But now, policy changes that effectively end PEPFAR have the potential to completely reverse course and the world could see HIV/AIDS infections on par with a time even before effective antivirals existed. In this episode: Dr. Chris Beyrer talks about his recent Lancet essay, “On Going Backwards,” why any retreat now will make it harder to regain lost ground, and how this policy change has the potential to impact millions of lives. Guest: Dr. Chris Beyrer is the past president of the International AIDS Society and an expert in global health and human rights. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: On Going Backwards—The Lancet (Perspectives) By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR funding—Journal of the International AIDS Society Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
In this special World AIDS Day episode of HIV unmuted, the IAS podcast, poet, advocate and researcher Bakita Kasadha joins host Juan Michael Porter II in a conversation that challenges preconceived notions and redefines how we discuss and address HIV stigma. Produced in collaboration with the IAS Heart of Stigma programme of IAS – the International AIDS Society – this episode dives into the transformative power of language, art and science in reshaping the global HIV narrative. Bakita shares her unique journey from poetry to advocacy and from being skeptical about research to becoming a groundbreaking researcher herself. Through candid dialogue, the episode explores the nuances of internalized stigma, the limitations of rigid language norms, and the necessity of inclusive and participatory approaches in HIV discourse. Bakita and Juan Michael discuss the role of grace, nuance, and allyship in dismantling stigma and how the arts can amplify voices and stories that have long been marginalized. This episode will leave you inspired to rethink stigma, reclaim narratives, and prioritize people in every aspect of the conversation. To find out how you can get involved this World AIDS Day (1 December), visit our World AIDS Day page. Meet our guest: Bakita Kasadha Bakita Kasadha is a multi-award-winning health researcher at the University of Oxford, and poet and activist. In 2024, she was awarded the IAS biennial Prudence Mabele Prize. She was the main researcher on the award-winning HIV and infant-feeding NOURISH-UK study and co-edited the collection, HIV and Women's Health: Where Are We Now? Her poetry, commissioned by organizations like the Elton John AIDS Foundation, has inspired initiatives such as a multimillion-pound Fast-Track Cities (London) fund to prevent HIV. She has written for TheBodyPro, NAM aidsmap, Black Ballad, Glamour and the British Journal of Healthcare Management. Her work focuses on addressing health inequities through research and the arts. Meet our host: Juan Michael Porter II Juan Michael Porter II is a health journalist, HIV advocate, culture critic, educator and the host of HIV unmuted, the IAS podcast. He is the Senior Editor of TheBody.com and TheBodyPro – and the first person openly living with HIV to hold the position. Juan Michael's reporting combines data dives, personal narratives and policy analyses to address the real-world consequences of ever-shifting legislation on people's health outcomes. He has written for the Public Broadcasting Service, SF Chronicle, Philadelphia Inquirer, Christian Science Monitor, NY Observer, TDF Stages, Playbill, American Theatre, Time Out NY, Queerty, Anti-Racism Daily, Positively Aware, Documentary Magazine, SYFY Wire, Scholastic and Dance Magazine.
E366 – "Inner Voice: A Heartfelt Chat with Dr. Foojan Zeine." In this episode, Dr. Foojan Zeine chats with Dr. John E. Lewis, Ph.D., the Founder and President of Dr Lewis Nutrition™ (https://www.drlewisnutrition.com) and past full-time Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He is also a Diplomate, Faculty Member, and Advisor of the Medical Wellness Association. He is a lecturer for the Institute for Brain Potential. With over 30 different studies as the principal investigator in his research career, Dr. Lewis has extensive experience in evaluating the effects of nutrition, dietary supplementation, and exercise on various aspects of human health and disease, instilling confidence in his knowledge. In addition to his research, Dr. Lewis has been invited as a national and international lecturer at conferences and workshops and as a guest on television shows, where he discusses his research findings and provides guidance and recommendations as an expert in the health and wellness field. He has over 180 peer-reviewed publications in scientific journals, where his work has first appeared in print, including some of the leading scientific journals, such as AIDS and Behavior, American Journal of Clinical Nutrition, American Journal of Public Health, Journal of the International AIDS Society, Journal of Strength and Conditioning Research, Nutrition, and Cancer: An International Journal, Sports Medicine, Stroke, The Journal of Alternative and Complementary Medicine, and The Gerontologist. He has also mentored many students, from undergraduates to post-doctoral trainees, in conducting clinical research and applying the principles of health promotion into daily practice. His seminal publication in the Journal of Alzheimer's Disease from his Alzheimer's study not only spurred him to leave academics and pursue a science-based business career but also enabled him to be selected for a widely-acclaimed TEDx Miami talk (https://www.youtube.com/watch?v=rOJr0sxmxGI) about how dietary supplementation can improve brain health. Dr. Lewis not only embodies the model of health and wellness by following a whole-food, plant-based diet for over 27 years, taking key dietary supplements, and maintaining a rigorous, daily exercise training program, but he also has a fervent passion for educating others about the value of nutrition, exercise, and health. His commitment to studying the application of clinical nutrition for the benefit of mankind is unwavering, reassuring the audience of his expertise in the field. In this episode, we will be talking about his latest research on the nutritional value of the polysaccharides found in Aloe Vera. www.DrLewisNutrition.com
The audio in this episode was recorded by Robbie during his time at the AIDS Conference in Munich recently. Please note that there is some wind interference in this recording but hopefully it won't affect your enjoyment too much. This week our special guest is Mario Campos. Mario is a 28-year-old influencer, speaker, and content creator. He is an ambassador for the National Minority AIDS Council and ViiV Health Care and an active member of the International AIDS Society through the CIPHER program. He won the "National Youth Award 2023" and was recognized as a "Young Influencer," awards granted by the Presidency of El Salvador. Veda will be back by Robbie's side in future episodes - have no fear! Love, Veda and Robbie. Poz Vibe Podcast is a Veda Lady and Robbie Lawlor production. Our continuity announcer this season is Anne Doyle. Big thanks to our sponsors Dublin Pride who make this series possible. Episodes are produced by Veda and Robbie with production assistance and editing by Esther O'Moore Donohoe. Artwork, social media assets and merch all created by the dazzling Lavender The Queen.
The International AIDS Society (IAS) has recently appointed a new president, Dr. Beatriz Greenstein. Dr. Greenstein, an infectious disease physician from Rio de Janeiro, has dedicated over 30 years to advancing HIV prevention and treatment. In an exclusive interview with our health and science journalist John Musenze, she shares her vision for the future of the IAS and what we can expect over the next two years.
We talk with the nicest person in Implementation Science, Byron Powell about how his dream of being a high school social worker and basketball coach was derailed by the irresistible siren song of implementation science, the meaning of interventions and implementation strategies, the utility of mechanism diagramming using approaches like logic models and causal pathway diagrams, and Kevin and I get Byron started on a rant about implementation science. Contact Byron @byron_powell on X Discussed during today's show: Geng, E. H., Nash, D., Phanuphak, N., Green, K., Solomon, S., Grimsrud, A., Sohn, A. H., Mayer, K. H., Bärnighausen, T., & Bekker, L. G. (2022). The question of the question: impactful implementation science to address the HIV epidemic. Journal of the International AIDS Society, 25(4), e25898. https://doi.org/10.1002/jia2.25898 Powell, B.J., Waltz, T.J., Chinman, M.J. et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implementation Sci 10, 21 (2015). https://doi.org/10.1186/s13012-015-0209-1 Pullmann, M. D., Dorsey, S., Duong, M. T., Lyon, A. R., Muse, I., Corbin, C. M., Davis, C. J., Thorp, K., Sweeney, M., Lewis, C. C., & Powell, B. J. (2022). Expect the Unexpected: A Qualitative Study of the Ripple Effects of Children's Mental Health Services Implementation Efforts. Implementation research and practice, 3, 26334895221120797. https://doi.org/10.1177/26334895221120797 Smith, J. D., Li, D. H., Merle, J. L., Keiser, B., Mustanski, B., & Benbow, N. D. (2024). Adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations. Implementation science : IS, 19(1), 10. https://doi.org/10.1186/s13012-024-01345-z
With the International AIDS Society's 25th global conference taking place next week in Munich, Mark Lagon, Chief Policy Officer at Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria and Bennett Freeman, Associate Fellow with Chatham House, joined Katherine to discuss a new Friends report regarding the role of the private sector and civil society organizations in advocating for global health programs, including HIV services. Lagon and Freeman argue that in a period during which restrictions on civic space seem to be increasing in many countries around the world, there is a business case to be made for the private sector in defending civil society organizations' efforts to promote respect for human rights, monitor for equitable access to services, and encourage transparency and accountability within global health programs and beyond.
John E. Lewis, Ph.D. is the Founder and President of Dr Lewis Nutrition™ and past full-time Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He is also a Diplomat, Faculty Member, and Advisor of the Medical Wellness Association. He is a lecturer for the Institute for Brain Potential. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, and exercise on various aspects of human health and disease. In addition to his research, Dr. Lewis has been an invited national and international lecturer at conferences and workshops and as a guest on television shows, where he discusses the findings of his research and provides guidance and recommendations as an expert in the field of health and wellness. He has over 180 peer-reviewed publications in scientific journals, where his work has first appeared in print, including some of the leading scientific journals, such as AIDS and Behavior, American Journal of Clinical Nutrition, American Journal of Public Health, Journal of the International AIDS Society, Journal of Strength and Conditioning Research, Nutrition and Cancer: An International Journal, Sports Medicine, Stroke, The Journal of Alternative and Complementary Medicine, and The Gerontologist. He has also mentored many different students, from undergraduates to post-doctoral trainees, in how to conduct clinical research and how to apply the principles of health promotion into daily practice. His seminal publication in the Journal of Alzheimer's Disease from his Alzheimer's study not only spurred him to leave academics and pursue a science-based business career, but also enabled him to be selected for a widely-acclaimed TEDxMiami talk about how dietary supplementation can improve brain health. Dr. Lewis also embodies the model of health and wellness by eating a whole-food, plant-based diet for over 27 years, taking certain key dietary supplements, and through a rigorous, daily exercise training program. John has a passion for educating others about the value of nutrition, exercise, and health, and he will continue to study the application of clinical nutrition for the benefit of mankind. In this episode, we cover: - how he turned his love for learning into his career - what polysaccharides are and how they're beneficial for health - the benefits of polysaccharides on brain health - how taking care of your brain NOW sets you up for life ... and more! You can connect with him over on Instagram: @drlewisnutrition Or check out his website: drlewisnutrition.com You can learn more about me by following on IG @imperfectlypaigewellness or by checking out my blog, freebies, and offers on my website: https://imperfectlypaigewellness.com Please share with #PaigeTalksWellness to help get the word out about the show - and join the Imperfect Health Fam over on Facebook.
John E. Lewis, Ph.D., Nutrition, Supplements and Brain Care John E. Lewis, Ph.D. is the Founder and President of Dr Lewis Nutrition™ and past full-time Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, and exercise on various aspects of human health and disease. In addition to his research, Dr. Lewis has been an invited national and international lecturer at conferences and workshops and as a guest on television shows, where he discusses the findings of his research and provides guidance and recommendations as an expert in the field of health and wellness. He has over 180 peer-reviewed publications in scientific journals, where his work has first appeared in print, including some of the leading scientific journals, such as AIDS and Behavior, American Journal of Clinical Nutrition, American Journal of Public Health, Journal of the International AIDS Society, Journal of Strength and Conditioning Research, Nutrition and Cancer: An International Journal, Sports Medicine, Stroke, The Journal of Alternative and Complementary Medicine, and The Gerontologist. He has also mentored many different students, from undergraduates to post-doctoral trainees, in how to conduct clinical research and how to apply the principles of health promotion into daily practice. His seminal publication in the Journal of Alzheimer's Disease from his Alzheimer's study not only spurred him to leave academics and pursue a science-based business career, but also enabled him to be selected for a widely-acclaimed TEDxMiami talk about how dietary supplementation can improve brain health. Dr. Lewis earned his B.S. and M.S. degrees from the University of Tennessee in business administration and human physiology, respectively, and he has a Ph.D. from the University of Miami in educational and psychological studies. His Medical Wellness Training Expert Specialty areas and Speaking topics include: plant-based (vegan/vegetarian) nutrition; optimal nutrition for health, wellness, and performance; exercise programming – from weekend warriors to athletes; dietary supplementation for health and disease prevention; designing and conducting clinical research interventions; technical writing and professional publishing and presentation; and evaluation of research studies and data. In addition to his professional accomplishments, he is a former athlete and competitive body builder, who maintains a very rigorous exercise training regimen, takes certain important dietary supplements, and has eaten a whole-food, plant-based diet for over 26 years. Links mentioned in the post: Raw Pecan Pie Recipe Gena Hamshaw, Choosing Raw
Scientific Sense ® by Gill Eapen: Prof. Linda-Gail Bekker is Professor of Medicine at the University of Cape Town and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is a Past President of the International AIDS Society. Please subscribe to this channel: https://www.youtube.com/c/ScientificSense?sub_confirmation=1 --- Send in a voice message: https://podcasters.spotify.com/pod/show/scientificsense/message Support this podcast: https://podcasters.spotify.com/pod/show/scientificsense/support
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.DisclosuresShmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca and Karius, Inc.Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).Speaker for International AIDS Society and MDOutlook.Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.All of the relevant financial relationships listed for these individuals have been mitigated.
A new report published by the Global Commission on Drug Policy has emphasised that the global goal of ending the HIV and Hepatitis epidemics cannot be achieved, unless there are significant reforms to current drug policies which continue to discriminate against and criminalise the community of People Who Use Drugs, which results in them being unable to access testing, treatment and care. On this episode of #ConsiderThis Melisa Idris speaks to Professor Datuk Dr Adeeba Kamarulzaman, a member of the Global Commission on Drug Policy, the Immediate Past President of the International AIDS Society, and current President & Pro Vice-Chancellor at Monash University Malaysia.
*Trigger Warning: This episode of the podcast touches on topics involving suicide and bullying* In Singapore, the social stigma surrounding HIV and AIDS remains a significant challenge, lagging behind the rapid advancements in medical science. This persistent stigma, rooted in fear and prejudice, hampers efforts towards a more inclusive and informed society. In the second episode of the fourth season of IPS' On Diversity Podcast, our host Liang Kaixin, Associate Director at the Institute of Policy Studies and a former journalist, delves into this critical issue with Dr Rayner Tan, Assistant Professor at the Saw Swee Hock School of Public Health, and Terry Lim, Associate Director of Outreach Education and Testing at Action for AIDS. Their discussion revolves around the enduring misconceptions about HIV, the vital role of campaigns and sexual health education in dispelling these myths, and strategies like HIV self-testing kits to encourage early detection, especially for high-risk groups. Where to get help: Samaritans of Singapore Hotline: 1767 Institute of Mental Health's Helpline: 6389 2222 Singapore Association for Mental Health Helpline: 1800 283 7019 Action for AIDS: 6254 0212 You can also find a list of international helplines here. If someone you know is at immediate risk, call 24-hour emergency medical services. Find out more about HIV and AIDS in Singapore: CNA (2 February 2019): Commentary: Public attitudes of HIV have not moved beyond narratives of fear, prejudice from early years of global epidemic CNA (4 November 2021): Commentary: Could the use of COVID-19 self-test kits and vending machines be replicated for HIV testing? CNA (1 December 2022): 'They used to physically recoil': How stigma around Singaporeans with HIV changed over the years About our guests: Rayner Kay Jin Tan, Assistant Professor, Saw Swee Hock School of Public Health, National University of Singapore Dr Rayner Kay Jin Tan is an Assistant Professor at the NUS Saw Swee Hock School of Public Health and a sociobehavioural researcher by training. His research interests revolve broadly about the social determinants of health, community engagement, implementation science, and health equity of vulnerable communities. Rayner was a recipient of the Fulbright Visiting Research Scholarship for the academic year 2022/2023 and is receiving training in implementation sciences as a fellow of the HIV, Infectious Diseases, and Global Health Implementation Research Institute (HIGH-IRI) of the Washington University in St. Louis. He is currently deputy editor of a leading HIV scientific journal, the Journal of the International AIDS Society and a perspectives editor at the BMJ journal, Sexually Transmitted Infections. He also actively contributes to the organising and scientific committees of the International AIDS Society and International Union Against Sexually Transmitted Infections (IUSTI) conferences. He currently is the president of Project X Society serving the health and social needs of sex workers, and a Director at The Greenhouse Community Services Limited, a charity providing substance use recovery services for marginalised groups in Singapore. He also currently serves as the Vice President for the Society of Behavioural Health, Singapore and a co-lead at SG Mental Health Matters. Terry Lim, Associate Director, Outreach Education and Testing Action for AIDS Terry Lim has been working with AfA for over 12 years leading its heterosexual outreach work and yet is still learning and growing in this ever-changing environment especially as we deal with the new normal. Terry sees himself as a connector and a bridge, taking the policies and big picture on HIV, digesting and understanding them, and then translating it on the ground to the target audience. He has found some success in doing this to achieve and bring about change in behaviour over the years. More from On Diversity Season 4 Episode 1: The Dual Challenges of Poverty and Single Motherhood with Carrie Tan, MP, Founder of Daughters of Tomorrow and Elizabeth Quek, Programme Manager at AWARE Season 3 Episode 9: Being Biracial in Singapore with Shane Pereira, Research Associate at IPS and Dave Parkash, Co-Founder at Fook Kin Restaurant Season 3 Episode 8: Pregnancy and Maternity Discrimination with Sher-li Torrey, Founder of Mums@Work and Kalpana Vignehsa, Senior Research Fellow at IPS Season 3 Episode 7: Palliative Care for the Young and Old with Dr Chong Poh Heng, Medical Director at HCA Hospice Limited and Tay Jia Ying, an end-of-life doula and Founder of Happy Ever After Season 3 Episode 6: Social Worker Burnout with Louis Ng, MP for Nee Soon GRC and Cindy Ng-Tay, Director of Home at Children's Aid Society Season 3 Episode 5: Leaving the Law Profession with Andrew Chan, Partner at Allen & Gledhill LLP and Michelle Yeo, Of Counsel at LVM Law Chambers LLC Season 3 Episode 4: Racism at Work with Dharesheni Nedumaran, Head of Diversity, Equity and Inclusion, APAC, at Mediabrands and Shamil Zainuddin, Research Associate at IPS Social Lab Season 3 Episode 3: Ableism at Work with Cassandra Chiu, a vision impaired counsellor and advocate for PWDs, and Justin Lee, Senior Research Fellow at IPS See omnystudio.com/listener for privacy information.
Listen to this Podcast featuring Fletcher Yi-Chi Chiu who is the Director of Communications of Persons with HIV/AIDS Rights Advocacy Association of Taiwan (PRAA Taiwan) and also serves as Asia Pacific Board Member of Y+Global (Global Network of Young People Living with HIV). Fletcher is in conversation with CNS founder and Managing Editor Shobha Shukla, in lead up to Women Deliver 2023 and International HIV Science Congress of International AIDS Society in Brisbane, Australia.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.ThanksCNS team
Podcast Episode 97Professor Sharon Lewin AO FRACP FAHMSSharon Lewin is a remarkable woman. For a start, she has been heading up two global pandemics. Simultaneously. In 1989 Dr Lewin (as she then was), instead of seeking a medical appointment in some prestigious city hospital, chose to work in a small hospital in Kenya. It was here she became passionate about infectious diseases, specifically HIV. And it would be a path she continues to tread to this day. She's determined to find the cure. In 2014, she was appointed Director of the Peter Doherty Institute for Infection and Immunity and her research focuses on why HIV persists, and on developing clinical trials aimed at finding that cure. She's delivered more than 100 talks internationally and has published 280-plus papers. Whilst doing all that her other role in this field is as the President of the International Aids Society. A huge organisation which ‘convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being.' I believe there are about 14,000 members of the IAS.Oh, she's also been a leader and spokesperson for the Covid response since about January 2020 when her team were the 1st in the world to isolate, grow and then share the virus with other nations. Her ongoing education of others in this area has been a much wanted voice of reason with a steadying hand on the tiller. It was a privilege having a conversation with someone so focussed on helping humanity. It was an informative, down to earth and, at times, very funny chat.Head to the podcast to have a listen. The link is in my bio.Visit instagram @reallyinterestingwomen for further interviews and posts of interesting women in history. Follow the link to leave a review....and tell your friendshttps://podcasts.apple.com/au/podcast/really-interesting-women/id1526764849If you know of a potential guest or interesting woman in history, email me atreallyinterestingwomen@gmail.com
In this episode of The Healers Café, Manon Bolliger (facilitator and retired naturopath with 30+ years of practice) speaks with Dr John Lewis Ph.D. “Let food be thy medicine” and “You are what you eat.” For the transcript and full story go to: https://www.drmanonbolliger.com/dr-john-lewis Highlights from today's episode include: Dr. John Lewis So, when you when you give the body these concentrated polysaccharides that are very, very uncommon, if not completely out of the modern diet. You're essentially giving the cells the things that they need to Dr. John E. Lewis So, it's kind of like if you have a car, I use this very poor analogy, because I can't think of a better one. But if your car has water in the gas tank, and it's kind of sputtering along, it still runs, but it's sputtering and doesn't really drive that well. You get that water cleared out, and then you give it high test 93 grade gasoline. And now boom, suddenly, your car is running like its brand new again. That's exactly what giving these polysaccharides does to ourselves. Dr. John E. Lewis as we know as immunology has progressed over the last several decades, we know that the immune system interacts with all of our other major organ systems to really kind of survey what's going on and modulate and regulate inflammation and all these cytokines and growth factors. And so, if our immune system is crapping out on us, then that just involves every other major organ system. And then what happens? Your overall health is compromised. ABOUT DR JOHN LEWIS, PhD: John E. Lewis, Ph.D. is past full-time and current Voluntary Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and the Founder and President of Dr Lewis Nutrition™ https://www.drlewisnutrition.com. He is a Diplomate, Faculty Member, and Advisor of the Medical Wellness Association. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, exercise, and medical devices on various aspects of human health and disease. He and his colleagues have been continually searching for ways to help people achieve and maintain health through natural treatments that align with our physiology. In addition to his research, Dr. Lewis has been an invited national and international lecturer and guest speaker at conferences and as a guest on television shows, where he discusses not only the findings of his research, but to provide guidance and recommendations as an expert in the field of health and wellness. Furthermore, he has over 180 peer-reviewed publications in scientific journals, where his work has first appeared in print, including some of the leading scientific journals, such as AIDS and Behavior, American Journal of Clinical Nutrition, American Journal of Public Health, Journal of the International AIDS Society, Journal of Strength and Conditioning Research, Nutrition and Cancer: An International Journal, Sports Medicine, Stroke, The Journal of Alternative and Complementary Medicine, and The Gerontologist. He has also mentored many different students, from undergraduates to post-doctoral trainees, in how to conduct clinical research and to apply the principles of health promotion into daily practice. His seminal publication from the study in the Journal of Alzheimer's Disease, not only spurred him to leave academics and pursue a science-based business career, but also enabled him to be selected for a widely-acclaimed TEDxMiami talk https://www.youtube.com/watch?v=rOJr0sxmxGI) about how dietary supplementation can improve brain health. Dr. Lewis also embodies the model of health and wellness by eating a whole-food, plant-based diet for over 25 years, taking certain key dietary supplements, and through a rigorous, daily exercise training program. John has a passion for educating others about the value of nutrition, exercise, and health, and he will continue to study the application of clinical nutrition for the benefit of mankind. – Website | Instagram | LinkedIn | YouTube| Twitter | ABOUT MANON BOLLIGER As a recently De-Registered board-certified naturopathic physician & in practice since 1992, I've seen an average of 150 patients per week and have helped people ranging from rural farmers in Nova Scotia to stressed out CEOs in Toronto to tri-athletes here in Vancouver. My resolve to educate, empower and engage people to take charge of their own health is evident in my best-selling books: 'What Patients Don't Say if Doctors Don't Ask: The Mindful Patient-Doctor Relationship' and 'A Healer in Every Household: Simple Solutions for Stress'. I also teach BowenFirst™ Therapy through Bowen College and hold transformational workshops to achieve these goals. So, when I share with you that LISTENING to Your body is a game changer in the healing process, I am speaking from expertise and direct experience". Mission: A Healer in Every Household! For more great information to go to her weekly blog: http://bowencollege.com/blog. For tips on health & healing go to: https://www.drmanonbolliger.com/tips ABOUT THE HEALERS CAFÉ: Manon's show is the #1 show for medical practitioners and holistic healers to have heart to heart conversations about their day to day lives. Follow on Social – Facebook | Instagram | LinkedIn | YouTube | Twitter | Linktr.ee | Rumble * De-Registered, revoked & retired naturopathic physician after 30 years of practice in healthcare. Now resourceful & resolved to share with you all the tools to take care of your health & vitality! Remember to subscribe if you like our videos. Click the bell if you want to be one of the first people notified of a new release.
Neglecting your health and refusing to take responsibility for your wellness only leads down one path - biochemical devastation. The result? You play right into the hands of Big Pharma and become their perfect customer, not dead, not healthy and completely reliant on an evil system to survive. How can people awaken to this reality before it's too late? What's the ultimate motivation of the puppet masters? In this episode, Founder and President of Dr Lewis Nutrition, Dr John E Lewis joins me to talk about what's gone wrong in healthcare and how we can fix it. We are at the tipping point of the average person's health, and it's so unfortunate that people are led to believe that chronic disease is an inevitability. -Dr. John E Lewis Three Things We Learned Our species-level crisisHow do we snap the world out of the mass psychosis we've seen over the last few years? Why we're seeing a significant increase in neurodegenerative disordersWhat's the difference between natural and necessary inflammation and inflammation from biochemical devastation? The war on creationWhat do the puppet masters want to get out of us? Guest Bio John E. Lewis, Ph.D. is past full-time and current Voluntary Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and the Founder and President of Dr Lewis Nutrition (https://www.drlewisnutrition.com/). He is a Diplomate, Faculty Member, and Advisor of the Medical Wellness Association. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, exercise, and medical devices on various aspects of human health and disease. He and his colleagues have been continually searching for ways to help people achieve and maintain health through natural treatments that align with our physiology. In addition to his research, Dr. Lewis has been an invited national and international lecturer and guest speaker at conferences and as a guest on television shows, where he discusses not only the findings of his research, but to provide guidance and recommendations as an expert in the field of health and wellness. In addition, he has over 180 peer-reviewed publications in scientific journals, where his work has first appeared in print, including in some of the leading scientific journals, such as AIDS and Behavior, American Journal of Clinical Nutrition, American Journal of Public Health, Journal of the International AIDS Society, Journal of Strength and Conditioning Research, Nutrition and Cancer: An International Journal, Sports Medicine, Stroke, The Journal of Alternative and Complementary Medicine, and The Gerontologist. He has also mentored many different students, from undergraduates to post-doctoral trainees, in not only how to conduct clinical research but to apply the principles of health promotion into daily practice. A primary stimulus for the origin of Dr Lewis Nutrition occurred when Dr. Lewis ran his landmark study on how an aloe polysaccharide multi-nutrient complex improved cognitive and immune functioning after 12 months in persons with moderate to severe Alzheimer's disease, leading to the creation of the dietary supplement, Daily Brain Care. Between 5 and 6 million Americans (approximately 40 million worldwide) suffer from Alzheimer's disease today, and the Alzheimer's Association predicts that number to more than double by 2030. It is the 6th leading cause of death of Americans and has no known conventional medical treatment, prevention, or cure. The current combined paid-for-care (formal) and unpaid care (informal caregiving) costs associated with Alzheimer's are estimated to be over $500 billion per year, and the five FDA-approved drugs for dementia do little to improve the victim's condition. Thus, Daily Brain Care shows more efficacy as a dietary supplement than what are considered to be the best evidence-based medications. His seminal publication from the study in the Journal of Alzheimer's Disease, not only spurred him to leave academics and pursue a science-based business career, but also enabled him to be selected for a widely-acclaimed TEDxMiami talk (https://www.youtube.com/watch?v=rOJr0sxmxGI) about how dietary supplementation can improve brain health. Dr. Lewis also embodies the model of health and wellness by eating a whole-food, plant-based diet for over 25 years, taking certain key dietary supplements, and through a rigorous, daily exercise training program. John has a passion for educating others about the value of nutrition, exercise, and health, and he will study the application of clinical nutrition for the benefit of mankind. For more information, go to https://drlewisnutrition.com/ and email john@drjonlewis.com.
Many countries are breathing a sigh of relief for having come through an infectious disease pandemic. However, this is no time to pause - the world has been backsliding when it comes to the HIV pandemic, with progress slowing down amid COVID-19 and other global crises. Prof Dr Adeeba Kamarulzaman, Immediate Past President of the International AIDS Society, and infectious diseases physician at Universiti Malaya Medical Centre, sheds light on the findings of the UNAIDS' Global AIDS Update 2022 report, and how Malaysia is faring (hint: it's not good news).Image credit: Shutterstock
The history of the HIV response is woven into the International AIDS Conferences. Ground-breaking science and political activism at the conferences have uniquely shaped the trajectory of the response. Conferences in Canada have played key roles. In Montreal in 1989, protestors stormed the stage, establishing activism in the HIV response. In Vancouver in 1996, delegates celebrated a treatment revolution that saw HIV become a manageable condition. Today, AIDS 2022 returns to Montreal and also takes place virtually. But other crises like monkeypox, surging COVID-19 cases and climate change, remind us why now more than ever, we need to re-engage and follow the science. In this episode of HIV unmuted, the award-winning IAS podcast, we take a deep dive into the breaking science being released at AIDS 2022, address important access concerns at the International AIDS Conferences and understand how to translate cutting-edge science into meaningful action. Meet our guests: Erika Castellanos is Interim Executive Director of Global Action for Trans Equality (GATE). She tells us her story of growing up being denied basic human rights due to being trans and the difficulties she faced in accessing HIV medication. Erika helps analyse controversial visa issues around AIDS 2022, and helps us understand the community impact of the science being released at the conference. Linda-Gail Bekker, former IAS President and current Director of the Desmond Tutu HIV Centre at the University of Cape Town, dives into the breaking science being released at AIDS 2022 and translates what this means for the HIV response. John Nkengasong is tasked with leading some of the world's largest HIV programmes as the U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy at the U.S. Department of State. He talks to us about why AIDS 2022 is so important and his vision for the future of the HIV response. If you are listening to this episode before 29 July 2022 and want to learn more about the latest scientific breakthroughs in the HIV response, join us at the 24th International AIDS Conference (AIDS 2022) virtually or in-person in Montreal.For further information on how the innovations from COVID-19 can be applied to HIV, read the International AIDS Society's report.
Despite being first isolated and identified back in 1983, HIV - the virus that causes AIDS, has no vaccine or cure till today, although there is treatment for people living with HIV. In conjunction with World AIDS Day today, we check in with Dato’ Prof Dr Adeeba Kamarulzaman, President of the International AIDS Society, whether we’re close to a HIV vaccine, and if the case of a women from Argentina whose body has rid itself of the HIV virus can point us towards a cure. Image credit: apcom.org & Shutterstock Drop here!
As all eyes have been on the virus, other serious killer diseases took a backseat. Resources and staff were diverted, lockdowns were common all over the world and a very real fear of Covid-19 kept people away from clinics and hospitals. Claudia Hammond and her expert panel from Africa, Asia, Europe and Latin America look at the devastating impact of the pandemic on illnesses other than Covid, on global killers like tuberculosis, polio, measles and HIV/Aids. And they hear that the worldwide disruption to cancer care will inevitably lead to late diagnoses, late-stage cancer treatment and more deaths. Dr Ramya Ananthakrishnan runs REACH, which supports, cares for and organises treatment for TB patients in Chennai, India's fourth most populous city. She tells Claudia about how hard the pandemic hit the work they do. Claudia's guests include Dr Abeeba Kamarulzaman, Professor of Medicine and Infectious Diseases at the University of Malaya in Kuala Lumpur, Malaysia and the President of the International Aids Society; Dr Lucica Ditiu, respiratory physician originally from Romania, Executive Director of the Stop TB Partnership, Geneva, Switzerland; Dr Balcha Masresha, coordinator of the measles and rubella programmes for the World Health Organisation in Brazzaville, Congo and cancer physician Dr Carlos Barrios, Director of the Latin American Clinical Oncology Research Group from Brazil. Produced by: Fiona Hill and Maria Simons Studio Engineer: Bob Nettles
No episódio de hoje do nosso podcast da PEBMED em parceria com o Hospital de Amor, o médico de família Marcelo Gobbo comenta sobre ciência do HIV e novos resultados da profilaxia pré-exposição (PrEP) para o HIV. O tema foi discutido na 11ª Conferência IAS sobre Ciência do HIV (IAS 2021), evento organizado pela International Aids Society. No podcast, Marcelo Gobbo destaca informações importantes sobre a PrEP, como: modalidades disponíveis, PrEPs oferecidas pelo SUS e quais tipos estão em estudo. Confira!
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell discuss promising advances in the field of HIV vaccine research and how we can prepare for optimal rollout of an eventual HIV vaccine. Presenters:Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD , PGD (Research Ethics), MBE (Research Ethics), CIPSenior Principal Clinical Research ScientistCenter for Microbiology ResearchKEMRIResearch ProfessorDepartments of Global Health and Obstetrics and GynecologyUniversity of Washington,Nairobi, KenyaSeattle, WashingtonPeter Godfrey-Faussett, MBBS, FRCP(UK)Science AdvisorUnited Nations Joint Programme on HIV (UNAIDS)Professor of Infectious Diseases and International HealthLondon School of Hygiene and Tropical MedicineLondon, United KingdomNina Russell, MDDirector for TB and HIV PreventionBill & Melinda Gates FoundationSeattle, WashingtonLink to full series: https://bit.ly/2UgrQ12Link to the HIV unmuted series from IAS: https://hivunmuted.iasociety.org/Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.Presenters:Swati Gupta, DrPH, MPHVice President and Head of Emerging Infectious Diseases and Scientific StrategyInternational AIDS Vaccine InitiativeNew York, New YorkMarc Dixneuf, PhDDirector GeneralAIDESPantin, FranceSpecial Commentator: Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed SciDean of the Faculty of MedicineImperial CollegeLondon, United KingdomLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Médica Infectóloga. Miembro de la Sociedad Argentina de Infectología. Miembro de la International AIDS Society.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.Presenters:Susan Buchbinder, MDClinical ProfessorDepartments of Medicine, Epidemiology and BiostatisticsUniversity of California, San FranciscoDirector, Bridge HIVSan Francisco Department of Public HealthSan Francisco, California Jontraye DavisCommunity Program Manager FHI 360Adjunct InstructorNorth Carolina Central UniversityDurham, North CarolinaSpecial Commentator: Jerome H. Kim, MDDirector GeneralInternational Vaccine InstituteSeoul, South KoreaLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
In this episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.Presenters:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Chief Operating Officer Desmond Tutu HIV Foundation Deputy DirectorDesmond Tutu HIV Centre Past PresidentInternational AIDS Society Faculty of Health Sciences University of Cape Town Cape Town, South AfricaMaureen LubaAfrica Region Advocacy AdvisorGlobal Advocacy for HIV PreventionAIDS Vaccine Advocacy CoalitionLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Summary by Gina: In this podcast, I will share some public understanding of AIDS. And the common misconception—the stigma of AIDS and its causes are the major focus. In this process, the differences between China and the United States in this social problem will be compared, so as to better understand the impact of this problem on AIDS patients and put forward corresponding measures. In addition, the inclusion of interview clips not only strengthens the persuasive force of the explanation but also makes the audience feel the importance of the issue more directly. References 曹越, 黄笛, 刘小平, 郭昫澄, 李十月, 燕虹, 孟详喻, 方程, 曾宪涛. (2018). 中国医务人员艾滋病污名现状 meta 分析. 中国公共卫生, 34(8), 1182–1186. 段文杰, 李玉梅, 何啊龙, & 吴桐. (2021). 基于未感染者与感染者双重视角的艾滋病污名.心理科学进展, 29(2), 323.高晓虹. 中国新闻传播研究 2016 (上). BEIJING BOOK CO. INC., 2017. Bazzi, A. R., Drainoni, M. L., Biancarelli, D. L., Hartman, J. J., Mimiaga, M. J., Mayer, K. H., & Biello, K. B. (2019). Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC public health, 19(1), 1-10. Blake, Turan, J. M., Atkins, G., Kempf, M. -C., Clay, O. J., Raper, J. L., & Turan, B. (2017). Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence. AIDS and Behavior, 21(1), 238–247 Galindo, G. R. (2013). A loss of moral experience: Understanding HIV-related stigma in the New York City House and Ball Community. Am J Public Health, 103(2), 293–299 Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013). Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. Journal of the International AIDS Society, 16, 18640 Pantelic, Marija, Laurel Sprague, and Anne L. Stangl. (2019). "It's not “all in your head”: critical knowledge gaps on internalized HIV stigma and a call for integrating social and structural conceptualizations." BMC infectious diseases, 19(1), 1-8. World Health Organization. 2020, "Number of people (allages) living with HIV: Estimates by WHO Region". Retrieved April 4, 2020 from https://apps.who.int/gho/data/view.main.22100WHO?lang=en
A epidemia de HIV nos anos 1980 representa um marco para a Ciência. Os tratamentos eficazes que surgiram ao longo das últimas quatro décadas são fruto de uma cooperação científica inédita e do trabalho de pesquisadores que ainda hoje tentam entender o vírus e suas mutações. A estrutura utilizada nos 40 anos de estudos dedicados à descoberta de uma vacina contra o HIV, lembra Roger Tatoud, diretor-adjunto dos programas HIV na IAS (International Aids Society), que organiza a Conferência Mundial sobre a Aids na Suíça, sustentou as pesquisas e o sucesso que resultaram na descoberta dos imunizantes contra o SARS-Cov-2. “Muitos dos centros clínicos onde foram realizados testes para a Covid-19 eram utilizados para a pesquisa do HIV. Os cientistas envolvidos nas pesquisas com a Covid-19 são os mesmos que trabalhavam em estudos sobre o HIV”, explica Além do investimento massivo, houve também um engajamento coletivo do mundo científico no combate à Covid-19, com aumento da cooperação e compartilhamento de dados, o que permitiu avanços em tempo recorde. Os organismos que financiam as pesquisas sobre o HIV também são os mesmos que investem nos estudos sobre o SARS-Cov-2, lembra o representante da International Aids Society. “Houve um enorme suporte, que deve ser reconhecido, de 40 anos de investimento no HIV, que permitiu uma resposta rápida à Covid-19." Na entrevista à RFI Brasil, Roger Tatoud disse esperar que essa mesma “energia”, seja utilizada, no futuro, na busca por uma vacina contra o HIV. Há projetos em andamento, dificultados pela complexidade do vírus, mas uma das esperanças é a utilização do RNA mensageiro, adotada com sucesso nas vacinas contra a Covid-19. Essa tecnologia poderia “driblar” a alta capacidade de mutação do HIV, fazendo com que o organismo produza anticorpos independentemente da cepa. O pesquisador explica que o HIV é um vírus muito mais sofisticado do que o SARS-Cov-2, com cepas de diferentes famílias, o que dificulta o desenvolvimento de uma vacina. “Como vírus da Aids varia muito, bem mais do que o vírus da Covid-19, e tem muito mais variantes, os anticorpos, isolados, não reconhecem todas as cepas”, explica Tatoud sobre a dificuldade de criar uma vacina utilizando métodos clássicos, onde vírus inativados ou enfraquecidos provocam uma reação do sistema imunológico que protegem o corpo. Os cientistas detectaram até agora cinco novas variantes para o SARS-Cov-2: a britânica, a sul-africana, a brasileira, a nigeriana e a originária de Nova York. Essas mutações são esperadas e normais, explica o pesquisador. “A natureza é assim. Os vírus mudam, alguns mais do que outros”, diz. É o caso do HIV, mas também do vírus da gripe, por exemplo. “Por isso é necessário criar uma vacina diferente todos os anos, porque a cepa muda de um ano para outro. O HIV é assim, muda muito, dependendo da população e da área geográfica.” A triterapia, ou o famoso coquetel anti-HIV, ainda é tratamento mais eficaz no combate às cepas existentes, segundo ele. Mas há casos de resistência, que obrigam os cientistas a adaptar as moléculas para tratar os pacientes. Novas pistas de tratamento A IAS apresentou em janeiro resultados preliminares de um estudo que mostra que injeções regulares de um tipo específico de anticorpos monoclonais, chamado de VRC01, podem prevenir a contaminação. A pesquisa incluiu 4.600 homens e transgêneros no Brasil, Peru e Estados Unidos e mulheres na África subsaariana. Mas, mesmo tendo um amplo espectro, os anticorpos não reconhecem todos os vírus existentes. “Talvez seja necessário fazer mais estudos ou combinar diferentes anticorpos, para ver se funciona melhor”, explica o pesquisador. Roger Tatoud acredita também que a mudança da percepção coletiva em relação à gravidade do HIV influenciou os investimentos e as pesquisas. A imagem dos doentes em estado terminal nos hospitais, que aterrorizou o mundo nos anos 1980, ficou para trás. O coquetel faz com que os pacientes possam levar uma vida praticamente normal e novos medicamentos evitam a contaminação em caso de exposição. O HIV passou a ser visto como uma doença crônica. Além disso, a transmissão hoje pode ser totalmente evitada, diferentemente da Covid-19. “Todo mundo pode ser atingido, todo mundo pode ser contaminado e todo mundo tem medo. Já em relação ao HIV, existe um certo distanciamento”, ressalta. Roger Tatoud lembra que o vírus que gerou uma das piores epidemias do século 20 continua sendo uma doença que mata 800.000 pessoas por ano.
Dr. Kenneth Mayer is Medical Research Director and Co-Chair of The Fenway Institute. He is also a Professor of Medicine at Harvard Medical School; a Professor, Department of Global Health and Population at Harvard School of Public Health; and an Editor-in-Chief at the Journal of the International AIDS Society. Find out more about Dr. Mayer's work here.In this podcast we talk about the impact of non-affirming environments on health outcomes among lesbian, gay, bisexual and transgender (LGBT) persons, and the intersection of LGBT stigma with HIV-related stigma and racial discrimination. Dr. Mayer describes the education and training work that The Fenway Institute does to optimize healthcare with LGBT persons. He provides multiple ways to intervene in stigma, ranging from becoming comfortable talking about sexual orientation and gender identity, self-awareness of power dynamics, to structural and political changes. Episode hosted by Dr. Carmen Logie. Supported by funding from the Canada Foundation for Innovation and Canada Research Chairs program. Original music and podcast produced by Jupiter Productions, who have various production services available to support your podcast needs.
Mario Cesar Vilhena e Vivian Avelino-Silva conversam sobre "Determinantes Sociais da Saúde LGBT+" com Maria Amelia Veras, graduada em Medicina pela Universidade Federal de Pernambuco, tem mestrado em Medicina Preventiva pela Universidade de São Paulo (USP) e Saúde Pública pela Universidade da Califórnia (UC Berkeley), doutorado em Medicina pela USP, pós-doutorado pela Universidade da Califórnia (UCSF). Atua como professora adjunta no departamento de Saúde Coletiva na Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), coordenadora do programa de pós graduação em Saúde Coletiva na FCMSCSP e de grupos de pesquisa como o NUDHES (Núcleo de Pesquisa em Direitos Humanos e Saúde da População LGBT), pesquisadora do Observatório COVID-19 BR, integrante da International AIDS Society e da International Epidemiological Association. Indicações Cultura Transviada: "Valentina", filme dirigido por Cássio Pereira dos Santos; "Serei A", música de Linn da Quebrada e Liniker; "The Kids Are All Right" ou "Minhas Mães e Meu Pai", dirigido por Lisa Cholodenko; "Vida Trans - A Coragem de Existir", livro escrito por Amara Moira, João W. Nery, Márcia Rocha, T. Brant.
In this episode we speak with Bradley Silberzahn on his work on sex workers, police-sex worker interactions, and retention in the SAPPHIRE Study (a hard-to-reach population). Brad is a 2nd year graduate student in Sociology at the University of Texas at Austin. His research interests are in policing, the criminal justice system, harm reduction, and vulnerable populations, including people who use drugs and people who sell sex. Previously, Brad worked as a Senior Research Program Coordinator at the John Hopkins Bloomberg School of Public Health. Brad has been published in journals such as American Journal of Public Health, BMC Public Health, PLOS One, Addictive Behaviors, Journal of Urban Health, and Journal of the International AIDS Society. Find Brad on Twitter @BradSilberzahn. Follow The Criminology Academy on Facebook, twitter, or Instagram! To help with rapport, staff and participants were invited to add up to two songs to a Spotify playlist. Additionally, this playlist was played on the van for privacy purposes. Check out the playlist here or go to our website at thecriminologyacademy.com. Music by: www.bensound.com
Successes in reducing infections from Intravenous Drug Use as well as Mother to Infant transmission has been showcase of sensible policies that followed on global conversations around the epidemic. Will we continue to extend evidence-based policy formulation? Melisa Idris and Sharaad Kuttan speak to Professor Datuk Dr Adeeba Kamarulzaman, President, International AIDS Society, Vice-President (Malaysian AIDS Council) and the dean of the Faculty of Medicine at Universiti Malaya.
With the tagline, “Undetectable Means Untransmissible”, the development of PREP is the next step in the management of the epidemic. Are we following the science? Melisa Idris and Sharaad Kuttan speak to Professor Datuk Dr Adeeba Kamarulzaman, President, International AIDS Society, Vice-President (Malaysian AIDS Council) and the dean of the Faculty of Medicine at Universiti Malaya.
The 1st of December is World AIDS Day, and as at the end of 2019, the global death toll from AIDS was roughly 33 million people since its onset over 40 years ago. In all, 76 million people have been infected, and scientists estimate that another 1.7 million people continue to acquire HIV every year. Where does Malaysia stand in its fight against this epidemic? Melisa Idris and Sharaad Kuttan speak to Professor Datuk Dr Adeeba Kamarulzaman, President, International AIDS Society, Vice-President (Malaysian AIDS Council) and the dean of the Faculty of Medicine at Universiti Malaya.
Repunte en casos de #COVID-19 en México: Dr. Francisco Moreno, jefe de Medicina Interna del Hospital ABC, miembro del IAS (International AIDS Society).
In conversation with Dr Erica Charters and Robin Gorna. TORCH Goes Digital! presents a series of weekly live events Big Tent - Live Events! Performance Week Part of the Humanities Cultural Programme, one of the founding stones for the future Stephen A. Schwarzman Centre for the Humanities. How have societies responded to pandemics, throughout the world, and throughout time? What are the new narratives, meanings and cultures that emerge and shape emerging realities? As this conversation will remind us, there is no simple answer to the problem of disease – but disease is also far more than a medical or scientific problem. Robin Gorna will draw on her experiences with social movements and cultural responses to AIDS since the 1980s, which brought hope and massive social change in the midst of rage and death. She will discuss the many connections between the two pandemics - of cultural change, politics and people and emerging narratives, with reflections on her current experience of living with Covid-19 in her own body. Erica Charters will discuss a just-published special issue of Centaurus on ‘The history of epidemics in the time of COVID-19’, reflecting on how the discipline of the history of science and medicine has responded to the current pandemic. Sharing historical approaches to understanding disease, she will explore how historians have framed pandemics and what a long-term context might offer for our understanding of COVID-19. Biographies: Dr Erica Charters (History Faculty and Wolfson College) examines the history of war, disease, and bodies, particularly in the British and French empires. Her current research focuses on manpower during the eighteenth century, examining the history of bodies as well as the history of methods used to measure and enhance bodies, labour, and population as a whole, including the history of statistics. Since disease was the biggest threat to manpower in the early modern world, Erica looks at how disease environments – throughout the world – shaped military, commercial, and agricultural power, as well as how overseas experiences shaped European theories of medicine, biology, and race alongside political methodologies such as statistics and censuses. Erica's monograph Disease, War, and the Imperial State: The Welfare of British Armed Forces during the Seven Years War (Chicago, 2014) traces how responses to disease shaped military strategy, medical theory, and the nature of British imperial authority (awarded the AAHM 2016 George Rosen Prize and the SAHR 2014 Best First Book). To read more about Erica's recent publication, please visit: https://onlinelibrary.wiley.com/journal/16000498 Robin Gorna is an AIDS activist and feminist who has led global and local campaigns and organisations, including SheDecides (the global women’s rights movement that she co-founded 2017), the Partnership for Maternal, Newborn and Child Health (hosted by WHO), International AIDS Society, and Australian Federation of AIDS Organisations. She set up the global AIDS Team for DFID (Department for International Development) in 2003, and then moved to South Africa to lead the UK’s regional and national HIV and health programmes. She co-founded, and now chairs, the St John’s College Women’s Network. She studied Theology but spent far too much time involved in student drama until the end of her 2nd year when she saw an early performance of The Normal Heart (by Larry Kramer) and signed up as a volunteer with the UK’s new AIDS Charity, the Terrence Higgins Trust. She remains fascinated by the ways in which culture and the arts inspire social movements, including the global AIDS response. She publishes regularly and wrote one of the earliest books on women, Vamps, Virgins and Victims: how can women fight AIDS? She’s now working on a feminist memoir exploring a life lived between two pandemics. For more information, please visit Robin Gorna's website here: www.robingorna.com
In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19.Presenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineUniversity of ChicagoChicago, IllinoisContent based on a CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/2Q7GDp2
In this episode of AIDS 2020, Janet Fleischman speaks with Dr. Linda-Gail Bekker, the deputy director of the Desmond Tutu HIV Center at the University of Cape Town, CEO of the Desmond Tutu HIV Foundation, and former president of the International AIDS Society. They discuss the effects of the Covid-19 pandemic on the lives of adolescent girls and young women and the potential impact on the momentum of HIV prevention programs designed for this vulnerable population.
BizNews — Globally, South Africans punch far above their weight in many fields. It's quite an achievement for a country with less than 1% of the global population to have given the world Nelson Mandela, Desmond Tutu, Elon Musk, Trevor Noah and many of Europe's leading bankers. But until the coronavirus pandemic grabbed the national attention, apart from famous heart transplant pioneer Dr Chris Barnard the extraorodinary contribution by SA's scientists had passed most by. For instance, the country has produced a clutch of Nobel Prize winning scientists, one of whom, Prof Michael Levitt, is still very much alive. Among the SA heavyweights with huge global reputations is UCT Prof Linda-Gail Bekker, chief operating officer of the Desmond Tutu HIV Foundation. Prof Bekker is the immediate past president of the 11 000 member International Aids Society which hosts the world's largest health or development event in the world; is a Rockefeller University alumnus (25 Nobel prizewinners); and an advisor to the US's massive Aids outreach programme PEPFAR. In this interview, which ranges from pre-exposure prophylaxis to protecting the elderly, from fake news to BCG, her contribution is pure quality. A rare Rational Perspective in an increasingly noisy Covid-19 landscape.
BizNews — Globally, South Africans punch far above their weight in many fields. It's quite an achievement for a country with less than 1% of the global population to have given the world Nelson Mandela, Desmond Tutu, Elon Musk, Trevor Noah and many of Europe's leading bankers. But until the coronavirus pandemic grabbed the national attention, apart from famous heart transplant pioneer Dr Chris Barnard the extraorodinary contribution by SA's scientists had passed most by. For instance, the country has produced a clutch of Nobel Prize winning scientists, one of whom, Prof Michael Levitt, is still very much alive. Among the SA heavyweights with huge global reputations is UCT Prof Linda-Gail Bekker, chief operating officer of the Desmond Tutu HIV Foundation. Prof Bekker is the immediate past president of the 11 000 member International Aids Society which hosts the world's largest health or development event in the world; is a Rockefeller University alumnus (25 Nobel prizewinners); and an advisor to the US's massive Aids outreach programme PEPFAR. In this interview, which ranges from pre-exposure prophylaxis to protecting the elderly, from fake news to BCG, her contribution is pure quality. A rare Rational Perspective in an increasingly noisy Covid-19 landscape.
In this episode of AIDS 2020, Sara and Andrew speak with Dr. Chris Beyrer, Desmond M. Tutu Professor of Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, and Past President of the International AIDS Society. They discuss Sara's new commentary on World AIDS Day on the big questions facing the HIV community as it looks ahead to 2020. They also discuss the challenges of controlling HIV and reducing new infections, why we're not reaching HIV epidemic control goals, and how a human rights approach must be central to the global response and upcoming AIDS2020 conference.
Two things need to happen to achieve greater success in the global fight against HIV: dramatically reduce new infections and achieve viral suppression in those already living with the virus. In order to meet these goals, new infections must come down from an annual rate of 1.7-2 million that has been stagnant for a decade, viral suppression must be sustained and ensured for the more than 23 million people living with HIV (PLHIV) on anti-retroviral treatment (ART), and treatment must be provided to the more than 14 million PLHIV not on ART. New technology offers the potential to facilitate these efforts if they can be utilized effectively. The July 2019 International AIDS Society science conference in Mexico City highlighted several important technological innovations either already on the market or that will be available in the coming years including long-acting injectable treatment, pre-exposure prophylaxis (PrEP), implants, and broadly neutralizing antibodies as a vaccine. However, the ongoing experience of starting oral PrEP programs has demonstrated that taking new products to scale for impact is complex and that there are significant obstacles to ensuring access to those in need. On Tuesday, October 22, 2:30-5:00 pm, the CSIS Global Health Policy Center will host a public event to explore recent developments in HIV prevention and treatment technology, examine successes and challenges in integrating those products into existing service delivery, and discuss how global programs, such as PEPFAR and the Global Fund, need to adapt to ensure access and uptake. Fireside ChatDeborah Waterhouse CEO ViiV Healthcare Moderated byJ. Stephen Morrison Senior Vice President and Director CSIS Global Health Policy Center Panel DiscussionAmbassador Deborah L. Birx Coordinator of the United States Government Activities to Combat HIV/AIDS and U.S. Special Representative for Global Health Diplomacy PEPFAR Charles Lyons President and CEO Elizabeth Glaser Pediatric AIDS Foundation Mitchell Warren Executive Director AVAC Moderated bySara M. Allinder Executive Director and Senior Fellow CSIS Global Health Policy Center This event was made possible by the generous support of ViiV Healthcare.
On today’s episode, Dr. Dery talks with local HIV expert Dr. Chris Garnet about the recent findings from the International AIDS Society conference that took place last week in Mexico.
In this episode, Steve Morrison and Andrew Schwartz speak with Dr. Eric Goosby, UN Special Envoy on Tuberculosis. They discuss the turbulent 1990 International AIDS Society conference in San Francisco, and the upcoming conference in San Francisco and Oakland in July 2020, thirty years later. Dr. Goosby also talks about his personal experiences as a young physician caring for patients with HIV in San Francisco during the early 1980s crisis, the lessons learned over the decades from battling infectious diseases, and the ongoing search for a cure.
In this episode, Steve Morrison and Andrew Schwartz speak with Dr. Eric Goosby, UN Special Envoy on Tuberculosis. They discuss the turbulent 1990 International AIDS Society conference in San Francisco, and the upcoming conference in San Francisco and Oakland in July 2020, thirty years later. Dr. Goosby also talks about his personal experiences as a young physician caring for patients with HIV in San Francisco during the early 1980s crisis, the lessons learned over the decades from battling infectious diseases, and the ongoing search for a cure.
A Shot In the Arm is in Mexico for five special podcasts in association with the International AIDS Society at its IAS2019 clinical science conference. We share the key news coming off the conference floor and beyond, with a range of guests from around the world. Covering the latest developments in Ebola, TB and HIV testing, prevention and treatment, we offer our unique insights into the state of the world’s responses to global pandemics.Apple Podcastshttps://apple.co/2UWfVnnGoogle Podcastshttp://bit.ly/2VKPxdmiHeart Radiohttp://bit.ly/ashotinthearmpodcastSpotifyhttps://spoti.fi/2VJ6Rj9Stitcher http://bit.ly/2IwnSt5YouTubehttp://bit.ly/asita_youtube
Are the recent heat waves around the world a sign of things to come? Geoffrey Carr, our science editor, finds out at the meeting of the International AIDS Society what more needs to be done to eradicate the disease. Also, has liquid water on Mars finally been found? Kenneth Cukier hosts. See acast.com/privacy for privacy and opt-out information.
Are the recent heat waves around the world a sign of things to come? Geoffrey Carr, our science editor, finds out at the meeting of the International AIDS Society what more needs to be done to eradicate the disease. Also, has liquid water on Mars finally been found? Kenneth Cukier hosts. See acast.com/privacy for privacy and opt-out information.
HIV, democracy and adolescents in South Africa: An introduction to the Mzantsi Wakho study, by Rebecca Hodes. In this first episode we speak to Rebecca Hodes, who is the principal investigator of Mzantsi Wakho’s qualitative research. She is the Director of the AIDS and Society Research Unit, University of Cape Town, and an Honourary Affiliate of the Department of Social Policy and Investigation, Oxford University. Hodes studied history at Rhodes University, and received an M.Sc in the History of Medicine, Science and Technology and a D.Phil from Oxford University. She has published a monograph, Broadcasting the Pandemic: A History of HIV on South African Television (HSRC: Cape Town, 2014). Her academic work has been published widely in peer-reviewed journals, including African Affairs, the South African Medical Journal, the Journal of the International AIDS Society, and the Journal of Southern African Studies, as well as numerous edited volumes and collected editions.
The Canadian Medical Hall of Fame will soon honour Dr. Mark Wainberg for his achievements in HIV research and AIDS advocacy. From the initial identification of 3TC, one of the most widely used HIV treatments, to drawing unprecedented attention to global disparities in access to antiretrovirals as president of the International AIDS Society, Dr. Wainberg's work has helped save millions of lives worldwide. In this podcast, he joins CMAJ reporter Lauren Vogel to reflect on his legacy and new work towards a cure.
完整文稿请关注周六微信，或登录以下网址： http://english.cri.cn/7146/2014/07/25/2582s837636.htm This is NEWS Plus Special English. I'm Mark Griffiths in Beijing. Here is the news. An international AIDS conference has been held in Australia with tribute to several delegates who were killed en route to the gathering when their plane was shot down over Ukraine. Officials at the opening ceremony for the 20th International AIDS Conference in Melbourne held a moment of silence for the six AIDS researchers and activists killed aboard Malaysia Airlines Flight 17. All 298 people on board the plane died when it was shot down by a surface-to-air missile on July 17th as it flew over rebel-held eastern Ukraine. Among the passengers was prominent Dutch researcher Joep Lange, former president of the International AIDS Society, and spokesman Glenn Thomas of the World Health Organization based in Geneva. Around 12,000 scientists and activists from 200 countries attended the conference to discuss the latest developments in HIV and AIDS research. This is NEWS Plus Special English. A new government study shows the rate of HIV infections diagnosed in the United States each year fell by one-third over the past decade. Experts hailed it as hopeful news that the AIDS epidemic may be slowing in the U.S. Researchers say that the reasons for the drop are not clear. It might mean fewer new infections are occurring, or that most infected people already have been diagnosed so more testing won't necessarily find many more cases. The study result was released ahead of the International AIDS Conference which was held between July 20th and 25th in Melbourne, Australia. HIV is the virus that causes AIDS, which destroys the immune system. The World Health Organization estimates that 35 million people globally have the virus. In the United States, 1 million people are thought to be infected, though many don't know it. You are listening to NEWS Plus Special English. I'm Mark Griffiths in Beijing. Now is the time to get moonstruck. Forty-five years ago on Sunday, Apollo 11's Neil Armstrong and Buzz Aldrin became the first humans to set foot on the moon. Armstrong's "one small step for man and one giant leap for mankind" on the dusty lunar surface on July 20th, 1969, still stirs hearts. At the launch site at Florida's Kennedy Space Center, NASA honored Armstrong on Monday with a renaming ceremony of the historic Operations and Checkout Building. Both Aldrin and Michael Collins, the Apollo 11 command module pilot who orbited the moon, were there. People can join the celebration, at the very least, by walking out and looking at the moon over the weekend. The Armstrong family had said following his death in 2012 that those who wish to honor Neil can simply honor his example of service, accomplishment and modesty; and the next time we walk outside on a clear night and see the moon smiling down at us, we can think of Neil Armstrong and give him a wink. This is NEWS Plus Special English. China's first lunar rover, Yutu, or Jade Rabbit, is still functioning despite the malfunction of some of its equipment. According to Wu Wei-ren, chief designer of China's lunar probe project, Yutu has been woken up after the past dormant period, but the problems still exist. The rover will embrace another "working day", which is about 14 Earth days, in an abnormal state caused by mechanical failures. During the lunar night, there is no sunlight to provide power to Yutu's solar panel, and the extremely low temperatures can damage its delicate electronics, so the rover must "hibernate". The 140-kilogram, six-wheeled Yutu, is part of the Chang'e-3 lunar probe. It has outlived its designed lifespan of three months since it reached the moon in mid-December last year. The rover has completed its designated scientific and engineering tasks, analyzed major elements on the lunar surface and studied mineral resources. However, after almost six weeks of operation, the moon buggy reported a mechanical control problem in January, before entering its second period of dormancy. Since then, it has been unable to move any farther, remaining around 20 meters southwest of where it landed. Its antenna and solar panels cannot be folded, either. Chinese engineers blamed the problem on the "complicated lunar surface environment". You are listening to NEWS Plus Special English. I'm Mark Griffiths in Beijing. A 38-year-old man has died of plague in northwest China's Gansu Province. The case was reported in Jiuquan City, and the man died on July 16th. He had been in contact with a dead marmot, which is a member of the squirrel family. A total of 150 people who had close contact with him, have been put in quarantine and are under medical observation. None of them has reported any symptoms of the disease so far. China's National Health and Family Planning Commission has sent disease prevention and control specialists to the city to prevent the plague from spreading. Plague is categorized as a Class A infectious disease, the most serious category under China's Law on the Prevention and Treatment of Infectious Diseases.
This month marks the 30th anniversary of the first diagnosed case of AIDS. Bertrand Audoin, from the International AIDS Society, brings us up to date with the latest developments in the fight against the disease. Also this week, Francesco Capuccio from Warwick University explains the importance of sleep as a “health commodity” and the problems with its sacrifice, in our increasingly busy lives.
Could we soon see a cure for HIV/Aids? Francoise Barre-Sinoussi thinks so. She's the Nobel Prize-winner who helped first identify the virus 30 years ago. She argues that the need to pour money into fighting one of the world's most deadly diseases is as great as ever. Already nearly 30 million have died from it. But with budgets being cut, can we afford more expensive research?(Image: Francoise Barre-Sinoussi Credit: Getty Images)
Mark Wainberg, microbiologist, identified one of the most effective AIDS drugs, and served as president of the International AIDS Society, becoming a prominent voice on the world stage. Meet a researcher turned activist.
Mark Wainberg, microbiologist, identified one of the most effective AIDS drugs, and served as president of the International AIDS Society, becoming a prominent voice on the world stage. Meet a researcher turned activist.
July 24: experts review the International AIDS Society meeting.
Discussion of the malaria Special Report, and news from the International AIDS Society meeting in South Africa.
Discussion of the Ugandan research article concerning circumcision for HIV-positive men.
© 2020-2025 Ivy Podcast Discovery LLC
